AGP
UPCOMAGIMEXPHARM PHARMACEUTICAL JOINT STOCK COMPANY
Price history
AGP · VNDOct 6, 2026Nov 5, 2026
Volume profile, 21 sessions: most trading at 28,433–28,667 ₫; 70% of the volume within 27,967–30,067 ₫. The latest price is in a zone of average trading.
Each candle is one session: open, high, low and close; the bars underneath are volume.
Session statistics
Nov 5, 2026- Reference price
- 30,000 ₫
- Open
- No data available
- High
- No data available
- Low
- No data available
- Trading volume
- 9,200 shares
Financial metrics
2025- Revenue 2025
- No data available
- Net profit 2025
- No data available
- Equity 2025
- No data available
- Liabilities 2025
- No data available
- Revenue growth
- No data available
- Net profit margin
- No data available
- P/E (2025 earnings)
- No data available
- P/B (2025 equity)
- No data available
- Cash dividend 2025
- No data available
- Dividend yield
- No data available
2025 figures where available; missing data is marked. P/E and P/B use the latest price and 2025 figures. Dividend yield does not guarantee future payouts.
Company information
- Company name
- AGIMEXPHARM PHARMACEUTICAL JOINT STOCK COMPANY
- Ticker
- AGP
- Exchange
- UPCOM
- Industry
- Pharmaceuticals
- Listing date
- Oct 6, 2015
Data sources
Matched price (snapshot)
Market cap: Price × listed shares
Market cap estimated from price and listed shares.
Methodology and referencesTrading history
Saved sessions| Date | Close | Open | High | Low | Volume |
|---|---|---|---|---|---|
| Nov 5, 2026 | 29,000 | — | — | — | — |
| Nov 4, 2026 | 29,200 | — | — | — | — |
| Nov 3, 2026 | 30,100 | 29,300 | 30,100 | 29,300 | 14,400 |
| Nov 2, 2026 | 29,900 | 29,500 | 30,300 | 29,500 | 6,300 |
| Oct 30, 2026 | 29,500 | 30,200 | 30,300 | 29,500 | 11,300 |
| Oct 29, 2026 | 29,000 | 30,200 | 30,200 | 29,000 | 6,200 |
| Oct 28, 2026 | 30,000 | 30,200 | 30,200 | 29,200 | 10,700 |
| Oct 27, 2026 | 29,500 | 30,000 | 30,300 | 28,800 | 13,000 |
Prices: VND · Volume: shares. The current session may still be in progress.
For information only, not investment advice.Explore other stocks